The abstract is read at the publisher; the summary is JClub's.
In 9-month-old human A53T α-synuclein transgenic mice, increased colonic GFAP+ /LRRK2+ enteric glial cells is linked to intestinal epithelial barrier impairment and a shift toward secretory autophagy.
- Why it matters: Parkinson’s disease is associated with intestinal epithelial barrier changes and enteric gliosis, but how LRRK2 in enteric glia connects these processes remained unclear.
- What they did: The study assessed IBA-1 staining, intestinal motility, colonic α-synuclein and LRRK2 expression, mucins and Muc-2, tight junction proteins, and secretory autophagy, plus EGC–IEC co-cultures where α-synuclein and lipopolysaccharide promoted gliosis and LRRK2 up-regulation.
- The result: α-synuclein and lipopolysaccharide–driven enteric gliosis with glial LRRK2 up-regulation is linked to IEB impairment via secretory autophagy, suggesting a gut-brain axis contribution to bowel symptoms and central pathology.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.